April 30 – The United Soccer League’s new women’s top tier, the USL Super League, has signed a league-wide deal with Kitman Labs as it gears up for its inaugural season – opting for the Irish company’s centralised Performance Medicine system to underpin player health, wellness, and performance data.
All eight clubs in the Super League will use Kitman Labs’ iP: Intelligence Platform, specifically its Performance Medicine module, to create a unified operating system across the league. The software brings together medical and performance data into a single, configurable platform – giving clubs a full-picture view of player health, injury risk, and match-readiness in real time.
For a new league positioning itself as forward-thinking in both sporting and operational standards, the move is practical. It reduces inefficiencies and administrative bloat while encouraging a more evidence-based approach to athlete care. Standardised documentation, collaborative workflows between departments, and a league-wide data ecosystem also set the stage for future injury research and innovation.
“We have the opportunity to build a cutting-edge data and analytics infrastructure from the ground up – a secure, fully integrated and scalable platform that benefits the league, the clubs, and most importantly, the athletes,” said Amanda Vandersort, USL Super League President. “With this system in place, our medical and performance staff can make better decisions around injury prevention, rehab, return to play, load management, and overall athlete care.”
“We’re proud to partner with the USL Super League in its inaugural season and be part of this defining moment for women’s professional soccer,” said Stephen Smith, CEO and Founder of Kitman Labs.
“The league has a clear vision for innovation—prioritizing player health, performance, and longevity. With iP: Intelligence Platform, the USL has the foundation to scale and unify medical data management and analytics, equipping every club with the technology and intelligence needed to make data-informed decisions and elevate athlete care.”
Contact the writer of this story, Harry Ewing, at moc.l1746055819labto1746055819ofdlr1746055819owedi1746055819sni@g1746055819niwe.1746055819yrrah1746055819